Showing results (2101-2110 of 2,190) with videos related to

Sort By:
Pageof 219
Plos Medicine|August 10, 2016
Correction: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statementGretchen A Stevens, Leontine Alkema, Robert E Black, et al.
Lancet (London, England)|July 3, 2016
Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statementGretchen A Stevens, Leontine Alkema, Robert E Black, et al.
American Journal of Hematology|December 24, 2019
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 studyMartin Dreyling, Armando Santoro, Luigina Mollica, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Plos Medicine|June 29, 2016
Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statementGretchen A Stevens, Leontine Alkema, Robert E Black, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Journal of Autoimmunity|December 15, 2016
IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patientsInga Koneczny, Jo A A Stevens, Anna De Rosa, et al.
Eclinicalmedicine|December 1, 2025
Preprocedural screening for multidrug-resistant organisms in endoscopic retrograde cholangiopancreatography: an international, multicentre, cross-sectional observational studyKoen van der Ploeg, Margreet C Vos, Hardik Rughwani, et al.
Journal of Medical Internet Research|July 6, 2026
Centering Equity During Health Technology Innovation: Scoping Review of Methods and Research Adjustments to Promote Inclusive CoproductionKara Burns, Carrie Van Rensburg, Shoshana Bloom, et al.
Blood|March 29, 2020
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trialAndrew H Wei, Pau Montesinos, Vladimir Ivanov, et al.
Pageof 219